Last 12 months
Inside the activity.
2 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 2 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 26, 2021 Filed Mar 2, 2021 17:18 UTC |
Arcudi III Louis JDirector · President and CEO
|
GrantStock Option (right to buy) · Derivative | 400,000 | $0.00 Strike: $2.06 | $0.00 |
DisclosureSEC source: 0001544227-21-000010 · wf-form4_161472344947814.xml · derivative · entry 1 Arcudi III Louis J · CIK 0001419350 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 400,000 Underlying: Common Stock · 400,000 shares Expires 2031-02-25 F1 · derivative.exercise_date: 1. Twenty-five percent (25%) of the shares subject to this option shall vest on February 1, 2022, and one thirty-sixth (1/36th) of the remaining shares subject to this option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. However, all such options, to the extent outstanding immediately prior to a Change in Control (as defined in the 2019 Equity Incentive Plan), will be (or will be deemed to have been) fully vested and exercisable as of immediately prior to such Change in Control. Read SEC document |
| June 22, 2020 Filed Jun 23, 2020 11:06 UTC |
Dable Habib JDirector
|
GrantStock Option (right to buy) · Derivative | 12,000 | $0.00 Strike: $2.40 | $0.00 |
DisclosureSEC source: 0001544227-20-000031 · wf-form4_159291036057257.xml · derivative · entry 1 Dable Habib J · CIK 0001690773 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires 2030-06-21 F1 · derivative.exercise_date: One hundred percent (100%) of the shares subject to this option will vest on the earlier of (1) June 22, 2021 and (2) the date of the first Annual Meeting following the grant date, subject to the Reporting Person continuing to provide service to the Issuer through such date. Read SEC document |
| June 22, 2020 Filed Jun 23, 2020 07:07 UTC |
HOWE JOHN P MDDirector
|
GrantStock Option (right to buy) · Derivative | 12,000 | $0.00 Strike: $2.40 | $0.00 |
DisclosureSEC source: 0001544227-20-000034 · wf-form4_159291043384915.xml · derivative · entry 1 HOWE JOHN P MD · CIK 0001190348 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires 2030-06-21 F1 · derivative.exercise_date: One hundred percent (100%) of the shares subject to this option will vest on the earlier of (1) June 22, 2021 and (2) the date of the first Annual Meeting following the grant date, subject to the Reporting Person continuing to provide service to the Issuer through such date. Read SEC document |
| June 22, 2020 Filed Jun 23, 2020 07:05 UTC |
NICHOL GEOFFREYDirector
|
GrantStock Option (right to buy) · Derivative | 12,000 | $0.00 Strike: $2.40 | $0.00 |
DisclosureSEC source: 0001544227-20-000030 · wf-form4_159291032774054.xml · derivative · entry 1 NICHOL GEOFFREY · CIK 0001214505 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires 2030-06-21 F1 · derivative.exercise_date: One hundred percent (100%) of the shares subject to this option will vest on the earlier of (1) June 22, 2021 and (2) the date of the first Annual Meeting following the grant date, subject to the Reporting Person continuing to provide service to the Issuer through such date. Read SEC document |
| June 22, 2020 Filed Jun 23, 2020 11:07 UTC |
Gallagher Carol GiltnerDirector
|
GrantStock Option (right to buy) · Derivative | 12,000 | $0.00 Strike: $2.40 | $0.00 |
DisclosureSEC source: 0001544227-20-000033 · wf-form4_159291041152553.xml · derivative · entry 1 Gallagher Carol Giltner · CIK 0001329959 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires 2030-06-21 F1 · derivative.exercise_date: One hundred percent (100%) of the shares subject to this option will vest on the earlier of (1) June 22, 2021 and (2) the date of the first Annual Meeting following the grant date, subject to the Reporting Person continuing to provide service to the Issuer through such date. Read SEC document |
| June 22, 2020 Filed Jun 23, 2020 11:06 UTC |
Hedley Mary LynneDirector
|
GrantStock Option (right to buy) · Derivative | 12,000 | $0.00 Strike: $2.40 | $0.00 |
DisclosureSEC source: 0001544227-20-000032 · wf-form4_159291038570764.xml · derivative · entry 1 Hedley Mary Lynne · CIK 0001340823 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires 2030-06-21 F1 · derivative.exercise_date: One hundred percent (100%) of the shares subject to this option will vest on the earlier of (1) June 22, 2021 and (2) the date of the first Annual Meeting following the grant date, subject to the Reporting Person continuing to provide service to the Issuer through such date. Read SEC document |
| June 22, 2020 Filed Jun 23, 2020 11:07 UTC |
Nuechterlein CaroleDirector
|
GrantStock Option (right to buy) · Derivative | 12,000 | $0.00 Strike: $2.40 | $0.00 |
DisclosureSEC source: 0001544227-20-000035 · wf-form4_159291045464779.xml · derivative · entry 1 Nuechterlein Carole · CIK 0001665133 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires 2030-06-21 F1 · derivative.exercise_date: One hundred percent (100%) of the shares subject to this option will vest on the earlier of (1) June 22, 2021 and (2) the date of the first Annual Meeting following the grant date, subject to the Reporting Person continuing to provide service to the Issuer through such date. Read SEC document |
| June 22, 2020 Filed Jun 23, 2020 11:05 UTC |
Hindman James M.Director
|
GrantStock Option (right to buy) · Derivative | 12,000 | $0.00 Strike: $2.40 | $0.00 |
DisclosureSEC source: 0001544227-20-000029 · wf-form4_159291030142413.xml · derivative · entry 1 Hindman James M. · CIK 0001617615 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires 2030-06-21 F1 · derivative.exercise_date: One hundred percent (100%) of the shares subject to this option will vest on the earlier of (1) June 22, 2021 and (2) the date of the first Annual Meeting following the grant date, subject to the Reporting Person continuing to provide service to the Issuer through such date. Read SEC document |
| May 25, 2020 Filed May 27, 2020 21:34 UTC |
Owens Julia C.Director · President and CEO
|
GrantStock Option (right to buy) · Derivative | 282,000 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001209191-20-032485 · doc4.xml · derivative · entry 1 Owens Julia C. · CIK 0001760219 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 282,000 Underlying: Common Stock · 282,000 shares Expires 2030-05-24 F1 · derivative.exercise_date: Fifty percent (50%) of the shares subject to this option shall vest on the earlier of: (i) December 31, 2020 or (ii) the Board's approval of the achievement of certain performance criteria, and one twelfth (1/12th) of the remaining shares subject to this option shall vest in equal monthly installments thereafter, subject to the Reporting Person continuing to provide service to the Issuer through each such date. Read SEC document |
| May 25, 2020 Filed May 27, 2020 21:39 UTC |
JOSEPH TAMARA LGeneral Counsel and Secretary
|
GrantStock Option (right to buy) · Derivative | 80,000 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001209191-20-032487 · doc4.xml · derivative · entry 1 JOSEPH TAMARA L · CIK 0001433991 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,000 Underlying: Common Stock · 80,000 shares Expires 2030-05-24 F1 · derivative.exercise_date: Fifty percent (50%) of the shares subject to this option shall vest on the earlier of: (i) December 31, 2020 or (ii) the Board's approval of the achievement of certain performance criteria, and one twelfth (1/12th) of the remaining shares subject to this option shall vest in equal monthly installments thereafter, subject to the Reporting Person continuing to provide service to the Issuer through each such date. Read SEC document |
| May 25, 2020 Filed May 27, 2020 21:45 UTC |
Arcudi III Louis JChief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 80,000 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001209191-20-032489 · doc4.xml · derivative · entry 1 Arcudi III Louis J · CIK 0001419350 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,000 Underlying: Common Stock · 80,000 shares Expires 2030-05-24 F1 · derivative.exercise_date: Fifty percent (50%) of the shares subject to this option shall vest on the earlier of: (i) December 31, 2020 or (ii) the Board's approval of the achievement of certain performance criteria, and one twelfth (1/12th) of the remaining shares subject to this option shall vest in equal monthly installments thereafter, subject to the Reporting Person continuing to provide service to the Issuer through each such date. Read SEC document |
| May 25, 2020 Filed May 28, 2020 01:40 UTC |
Zeidan RyanChief Development Officer
|
GrantStock Option (right to buy) · Derivative | 80,000 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001209191-20-032488 · doc4.xml · derivative · entry 1 Zeidan Ryan · CIK 0001785724 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,000 Underlying: Common Stock · 80,000 shares Expires 2030-05-24 F1 · derivative.exercise_date: Fifty percent (50%) of the shares subject to this option shall vest on the earlier of: (i) December 31, 2020 or (ii) the Board's approval of the achievement of certain performance criteria, and one twelfth (1/12th) of the remaining shares subject to this option shall vest in equal monthly installments thereafter, subject to the Reporting Person continuing to provide service to the Issuer through each such date. Read SEC document |
| May 25, 2020 Filed May 28, 2020 01:38 UTC |
Arbet-Engels ChristopheChief Medical Officer
|
GrantStock Option (right to buy) · Derivative | 80,000 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001209191-20-032486 · doc4.xml · derivative · entry 1 Arbet-Engels Christophe · CIK 0001802615 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,000 Underlying: Common Stock · 80,000 shares Expires 2030-05-24 F1 · derivative.exercise_date: Fifty percent (50%) of the shares subject to this option shall vest on the earlier of: (i) December 31, 2020 or (ii) the Board's approval of the achievement of certain performance criteria, and one twelfth (1/12th) of the remaining shares subject to this option shall vest in equal monthly installments thereafter, subject to the Reporting Person continuing to provide service to the Issuer through each such date. Read SEC document |
| March 28, 2020 Filed Mar 31, 2020 21:03 UTC |
Zeidan RyanChief Development Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $4.80 | $0.00 |
DisclosureSEC source: 0001209191-20-021851 · doc4.xml · derivative · entry 1 Zeidan Ryan · CIK 0001785724 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2030-03-27 F1 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to this option shall vest on March 28, 2021, and one thirty-sixth (1/36th) of the remaining shares subject to this option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| February 10, 2020 Filed Feb 11, 2020 22:02 UTC |
Arbet-Engels ChristopheChief Medical Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 140,000 | $0.00 Strike: $6.90 | $0.00 |
DisclosureSEC source: 0001209191-20-008370 · doc4.xml · derivative · entry 1 Arbet-Engels Christophe · CIK 0001802615 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,000 Underlying: Common Stock · 140,000 shares Expires 2030-02-09 F1 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to this option shall vest on February 10, 2021, and one thirty-sixth (1/36th) of the remaining shares subject to this option shall vest each month thereafter, subject to the recipient continuing to provide service through that date. Read SEC document |
| January 31, 2020 Filed Feb 4, 2020 16:32 UTC |
Owens Julia C.Director · President and CEO
|
GrantEmployee Stock Option (right to buy) · Derivative | 215,000 | $0.00 Strike: $7.94 | $0.00 |
DisclosureSEC source: 0001209191-20-006367 · doc4.xml · derivative · entry 1 Owens Julia C. · CIK 0001760219 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 215,000 Underlying: Common Stock · 215,000 shares Expires 2030-01-30 F1 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to this option shall vest on January 7, 2021, and one thirty-sixth (1/36th) of the remaining shares subject to this option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| January 31, 2020 Filed Feb 4, 2020 16:31 UTC |
JOSEPH TAMARA LGeneral Counsel and Secretary
|
GrantEmployee Stock Option (right to buy) · Derivative | 56,250 | $0.00 Strike: $7.94 | $0.00 |
DisclosureSEC source: 0001209191-20-006361 · doc4.xml · derivative · entry 1 JOSEPH TAMARA L · CIK 0001433991 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,250 Underlying: Common Stock · 56,250 shares Expires 2030-01-30 F1 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to this option shall vest on January 7, 2021, and one thirty-sixth (1/36th) of the remaining shares subject to this option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| January 31, 2020 Filed Feb 4, 2020 16:29 UTC |
Arcudi III Louis JChief Financial Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 71,250 | $0.00 Strike: $7.94 | $0.00 |
DisclosureSEC source: 0001209191-20-006345 · doc4.xml · derivative · entry 1 Arcudi III Louis J · CIK 0001419350 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,250 Underlying: Common Stock · 71,250 shares Expires 2030-01-30 F1 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to this option shall vest on January 7, 2021, and one thirty-sixth (1/36th) of the remaining shares subject to this option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| January 31, 2020 Filed Feb 4, 2020 21:30 UTC |
Zeidan RyanChief Development Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 41,250 | $0.00 Strike: $7.94 | $0.00 |
DisclosureSEC source: 0001209191-20-006355 · doc4.xml · derivative · entry 1 Zeidan Ryan · CIK 0001785724 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,250 Underlying: Common Stock · 41,250 shares Expires 2030-01-30 F1 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to this option shall vest on January 7, 2021, and one thirty-sixth (1/36th) of the remaining shares subject to this option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| December 17, 2019 Filed Dec 19, 2019 17:23 UTC |
NICHOL GEOFFREYDirector
|
GrantStock Option (right to buy) · Derivative | 24,000 | $0.00 Strike: $6.29 | $0.00 |
DisclosureSEC source: 0001209191-19-061358 · doc4.xml · derivative · entry 1 NICHOL GEOFFREY · CIK 0001214505 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,000 Underlying: Common Stock · 24,000 shares Expires 2029-12-16 F1 · derivative.exercise_date: One third (1/3rd) of the shares subject to the option shall vest on December 17, 2020, and one twenty-fourth (1/24th) of the remaining shares subject to the option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| August 19, 2019 Filed Aug 20, 2019 20:39 UTC |
JOSEPH TAMARA LGeneral Counsel and Secretary
|
GrantEmployee Stock Option (right to buy) · Derivative | 130,000 | $0.00 Strike: $7.27 | $0.00 |
DisclosureSEC source: 0001209191-19-046918 · doc4.xml · derivative · entry 1 JOSEPH TAMARA L · CIK 0001433991 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,000 Underlying: Common Stock · 130,000 shares Expires 2029-08-18 F1 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to this option shall vest on August 19, 2020, and one thirty-sixth (1/36th) of the remaining shares subject to this option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| August 19, 2019 Filed Aug 21, 2019 00:38 UTC |
Zeidan RyanChief Development Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $7.27 | $0.00 |
DisclosureSEC source: 0001209191-19-046917 · doc4.xml · derivative · entry 1 Zeidan Ryan · CIK 0001785724 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2029-08-18 F1 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to this option shall vest on August 19, 2020, and one thirty-sixth (1/36th) of the remaining shares subject to this option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| June 20, 2019 Filed Jun 21, 2019 16:40 UTC |
Owens Julia C.Director · President and CEO
|
GrantEmployee Stock Option (right to buy) · Derivative | 76,007 | $0.00 Strike: $11.59 | $0.00 |
DisclosureSEC source: 0001209191-19-038488 · doc4.xml · derivative · entry 1 Owens Julia C. · CIK 0001760219 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,007 Underlying: Common Stock · 76,007 shares Expires 2029-06-19 F1 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to this option shall vest on June 20, 2020, and one thirty-sixth (1/36th) of the remaining shares subject to this option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| June 20, 2019 Filed Jun 21, 2019 20:34 UTC |
Dable Habib JDirector
|
GrantStock Option (right to buy) · Derivative | 12,000 | $0.00 Strike: $11.59 | $0.00 |
DisclosureSEC source: 0001209191-19-038478 · doc4.xml · derivative · entry 1 Dable Habib J · CIK 0001690773 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires 2029-06-19 F1 · derivative.exercise_date: One hundred percent (100%) of the shares subject to this option will vest on June 20, 2020, subject to the Reporting Person continuing to provide service through such date. Read SEC document |
| June 20, 2019 Filed Jun 21, 2019 16:33 UTC |
Arcudi III Louis JChief Financial Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $11.59 | $0.00 |
DisclosureSEC source: 0001209191-19-038475 · doc4.xml · derivative · entry 1 Arcudi III Louis J · CIK 0001419350 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2029-06-19 F1 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to this option shall vest on June 20, 2020, and one thirty-sixth (1/36th) of the remaining shares subject to this option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| June 20, 2019 Filed Jun 21, 2019 16:38 UTC |
HOWE JOHN P MDDirector
|
GrantStock Option (right to buy) · Derivative | 12,000 | $0.00 Strike: $11.59 | $0.00 |
DisclosureSEC source: 0001209191-19-038485 · doc4.xml · derivative · entry 1 HOWE JOHN P MD · CIK 0001190348 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires 2029-06-19 F1 · derivative.exercise_date: One hundred percent (100%) of the shares subject to this option will vest on June 20, 2020, subject to the Reporting Person continuing to provide service through such date. Read SEC document |
| June 20, 2019 Filed Jun 21, 2019 16:41 UTC |
WHITCOMB RANDALL WDirector
|
GrantStock Option (right to buy) · Derivative | 12,000 | $0.00 Strike: $11.59 | $0.00 |
DisclosureSEC source: 0001209191-19-038489 · doc4.xml · derivative · entry 1 WHITCOMB RANDALL W · CIK 0001218867 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires 2029-06-19 F1 · derivative.exercise_date: One hundred percent (100%) of the shares subject to this option will vest on June 20, 2020, subject to the Reporting Person continuing to provide service through such date. Read SEC document |
| June 20, 2019 Filed Jun 21, 2019 20:36 UTC |
Hedley Mary LynneDirector
|
GrantStock Option (right to buy) · Derivative | 12,000 | $0.00 Strike: $11.59 | $0.00 |
DisclosureSEC source: 0001209191-19-038481 · doc4.xml · derivative · entry 1 Hedley Mary Lynne · CIK 0001340823 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires 2029-06-19 F1 · derivative.exercise_date: One hundred percent (100%) of the shares subject to this option will vest on June 20, 2020, subject to the Reporting Person continuing to provide service through such date. Read SEC document |
| June 20, 2019 Filed Jun 21, 2019 20:35 UTC |
Gallagher Carol GiltnerDirector
|
GrantStock Option (right to buy) · Derivative | 12,000 | $0.00 Strike: $11.59 | $0.00 |
DisclosureSEC source: 0001209191-19-038479 · doc4.xml · derivative · entry 1 Gallagher Carol Giltner · CIK 0001329959 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires 2029-06-19 F1 · derivative.exercise_date: One hundred percent (100%) of the shares subject to this option will vest on June 20, 2020, subject to the Reporting Person continuing to provide service through such date. Read SEC document |
| June 20, 2019 Filed Jun 21, 2019 20:39 UTC |
Nuechterlein CaroleDirector
|
GrantStock Option (right to buy) · Derivative | 12,000 | $0.00 Strike: $11.59 | $0.00 |
DisclosureSEC source: 0001209191-19-038486 · doc4.xml · derivative · entry 1 Nuechterlein Carole · CIK 0001665133 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires 2029-06-19 F1 · derivative.exercise_date: One hundred percent (100%) of the shares subject to this option will vest on June 20, 2020, subject to the Reporting Person continuing to provide service through such date. Read SEC document |
| June 20, 2019 Filed Jun 21, 2019 20:37 UTC |
Hindman James M.Director
|
GrantStock Option (right to buy) · Derivative | 12,000 | $0.00 Strike: $11.59 | $0.00 |
DisclosureSEC source: 0001209191-19-038482 · doc4.xml · derivative · entry 1 Hindman James M. · CIK 0001617615 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires 2029-06-19 F1 · derivative.exercise_date: One hundred percent (100%) of the shares subject to this option will vest on June 20, 2020, subject to the Reporting Person continuing to provide service through such date. Read SEC document |
| January 15, 2019 Filed Jan 17, 2019 16:44 UTC |
Brinza Jeffery M.Sec., CAO and General Counsel
|
GrantEmployee Stock Option (right to buy) · Derivative | 56,000 | $0.00 Strike: $8.80 | $0.00 |
DisclosureSEC source: 0001209191-19-004228 · doc4.xml · derivative · entry 1 Brinza Jeffery M. · CIK 0001760214 · Sec., CAO and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,000 Underlying: Common Stock · 56,000 shares Expires 2029-01-14 F1 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to this option shall vest on January 15, 2020, and one thirty-sixth (1/36th) of the remaining shares subject to this option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| January 15, 2019 Filed Jan 17, 2019 16:50 UTC |
Owens Julia C.Director · President and CEO
|
GrantEmployee Stock Option (right to buy) · Derivative | 173,993 | $0.00 Strike: $8.80 | $0.00 |
DisclosureSEC source: 0001209191-19-004245 · doc4.xml · derivative · entry 1 Owens Julia C. · CIK 0001760219 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 173,993 Underlying: Common Stock · 173,993 shares Expires 2029-01-14 F1 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to this option shall vest on January 15, 2020, and one thirty-sixth (1/36th) of the remaining shares subject to this option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| January 15, 2019 Filed Jan 17, 2019 21:45 UTC |
Dable Habib JDirector
|
GrantStock Option (right to buy) · Derivative | 6,000 | $0.00 Strike: $8.80 | $0.00 |
DisclosureSEC source: 0001209191-19-004231 · doc4.xml · derivative · entry 1 Dable Habib J · CIK 0001690773 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Underlying: Common Stock · 6,000 shares Expires 2029-01-14 F1 · derivative.exercise_date: One hundred percent (100%) of the shares subject to this option will vest on January 15, 2020, subject to the Reporting Person continuing to provide service through such date. Read SEC document |
| January 15, 2019 Filed Jan 17, 2019 16:43 UTC |
Arcudi III Louis JChief Financial Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $8.80 | $0.00 |
DisclosureSEC source: 0001209191-19-004226 · doc4.xml · derivative · entry 1 Arcudi III Louis J · CIK 0001419350 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2029-01-14 F1 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to this option shall vest on January 15, 2020, and one thirty-sixth (1/36th) of the remaining shares subject to this option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| January 15, 2019 Filed Jan 17, 2019 16:48 UTC |
HOWE JOHN P MDDirector
|
GrantStock Option (right to buy) · Derivative | 6,000 | $0.00 Strike: $8.80 | $0.00 |
DisclosureSEC source: 0001209191-19-004241 · doc4.xml · derivative · entry 1 HOWE JOHN P MD · CIK 0001190348 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Underlying: Common Stock · 6,000 shares Expires 2029-01-14 F1 · derivative.exercise_date: One hundred percent (100%) of the shares subject to this option will vest on January 15, 2020, subject to the Reporting Person continuing to provide service through such date. Read SEC document |
| January 15, 2019 Filed Jan 17, 2019 16:52 UTC |
WHITCOMB RANDALL WDirector
|
GrantStock Option (right to buy) · Derivative | 6,000 | $0.00 Strike: $8.80 | $0.00 |
DisclosureSEC source: 0001209191-19-004246 · doc4.xml · derivative · entry 1 WHITCOMB RANDALL W · CIK 0001218867 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Underlying: Common Stock · 6,000 shares Expires 2029-01-14 F1 · derivative.exercise_date: One hundred percent (100%) of the shares subject to this option will vest on January 15, 2020, subject to the Reporting Person continuing to provide service through such date. Read SEC document |
| January 15, 2019 Filed Jan 17, 2019 21:46 UTC |
Gallagher Carol GiltnerDirector
|
GrantStock Option (right to buy) · Derivative | 6,000 | $0.00 Strike: $8.80 | $0.00 |
DisclosureSEC source: 0001209191-19-004235 · doc4.xml · derivative · entry 1 Gallagher Carol Giltner · CIK 0001329959 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Underlying: Common Stock · 6,000 shares Expires 2029-01-14 F1 · derivative.exercise_date: One hundred percent (100%) of the shares subject to this option will vest on January 15, 2020, subject to the Reporting Person continuing to provide service through such date. Read SEC document |
| January 15, 2019 Filed Jan 17, 2019 21:46 UTC |
Hedley Mary LynneDirector
|
GrantStock Option (right to buy) · Derivative | 6,000 | $0.00 Strike: $8.80 | $0.00 |
DisclosureSEC source: 0001209191-19-004237 · doc4.xml · derivative · entry 1 Hedley Mary Lynne · CIK 0001340823 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Underlying: Common Stock · 6,000 shares Expires 2029-01-14 F1 · derivative.exercise_date: One hundred percent (100%) of the shares subject to this option will vest on January 15, 2020, subject to the Reporting Person continuing to provide service through such date. Read SEC document |
| January 15, 2019 Filed Jan 17, 2019 21:47 UTC |
Hindman James M.Director
|
GrantStock Option (right to buy) · Derivative | 6,000 | $0.00 Strike: $8.80 | $0.00 |
DisclosureSEC source: 0001209191-19-004239 · doc4.xml · derivative · entry 1 Hindman James M. · CIK 0001617615 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Underlying: Common Stock · 6,000 shares Expires 2029-01-14 F1 · derivative.exercise_date: One hundred percent (100%) of the shares subject to this option will vest on January 15, 2020, subject to the Reporting Person continuing to provide service through such date. Read SEC document |
| January 15, 2019 Filed Jan 17, 2019 21:49 UTC |
Mohideen PharisChief Medical Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 64,000 | $0.00 Strike: $8.80 | $0.00 |
DisclosureSEC source: 0001209191-19-004242 · doc4.xml · derivative · entry 1 Mohideen Pharis · CIK 0001760395 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,000 Underlying: Common Stock · 64,000 shares Expires 2029-01-14 F1 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to this option shall vest on January 15, 2020, and one thirty-sixth (1/36th) of the remaining shares subject to this option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| January 15, 2019 Filed Jan 17, 2019 21:50 UTC |
Nuechterlein CaroleDirector
|
GrantStock Option (right to buy) · Derivative | 6,000 | $0.00 Strike: $8.80 | $0.00 |
DisclosureSEC source: 0001209191-19-004243 · doc4.xml · derivative · entry 1 Nuechterlein Carole · CIK 0001665133 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Underlying: Common Stock · 6,000 shares Expires 2029-01-14 F1 · derivative.exercise_date: One hundred percent (100%) of the shares subject to this option will vest on January 15, 2020, subject to the Reporting Person continuing to provide service through such date. Read SEC document |
| December 07, 2018 Filed Dec 11, 2018 19:36 UTC |
Brinza Jeffery M.Sec., CAO and General Counsel
|
GrantEmployee Stock Option (right to buy) · Derivative | 44,639 | Not disclosed Strike: $16.40 | Not disclosed |
DisclosureSEC source: 0001209191-18-062106 · doc4.xml · derivative · entry 2 Brinza Jeffery M. · CIK 0001760214 · Sec., CAO and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,639 Underlying: Common Stock · 44,639 shares Expires 2028-08-23 F4 · price: Received in connection with the Merger in exchange for a stock option to acquire 600,000 shares of Millendo common stock for $1.22 per share. F3 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to the option shall vest on August 20, 2019, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| December 07, 2018 Filed Dec 11, 2018 19:36 UTC |
Brinza Jeffery M.Sec., CAO and General Counsel
|
GrantEmployee Stock Option (right to buy) · Derivative | 49,609 | Not disclosed Strike: $4.44 | Not disclosed |
DisclosureSEC source: 0001209191-18-062106 · doc4.xml · derivative · entry 1 Brinza Jeffery M. · CIK 0001760214 · Sec., CAO and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,609 Underlying: Common Stock · 49,609 shares Expires 2026-01-27 F2 · price: Received in connection with the merger of Millendo Therapeutics, Inc. ("Millendo") into the Issuer (the "Merger") in exchange for a stock option to acquire 666,800 shares of Millendo common stock for $0.33 per share. F1 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to the option vested on August 24, 2016, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| December 07, 2018 Filed Dec 11, 2018 19:49 UTC |
Owens Julia C.Director · President and CEO
|
GrantEmployee Stock Option (right to buy) · Derivative | 174,839 | Not disclosed Strike: $16.40 | Not disclosed |
DisclosureSEC source: 0001209191-18-062126 · doc4.xml · derivative · entry 4 Owens Julia C. · CIK 0001760219 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 174,839 Underlying: Common Stock · 174,839 shares Expires 2028-08-23 F7 · price: Received in connection with the Merger in exchange for a stock option to acquire 2,350,000 shares of Millendo common stock for $1.22 per share. F6 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to the option shall vest on August 20, 2019, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| December 07, 2018 Filed Dec 11, 2018 19:49 UTC |
Owens Julia C.Director · President and CEO
|
GrantEmployee Stock Option (right to buy) · Derivative | 151,600 | Not disclosed Strike: $4.44 | Not disclosed |
DisclosureSEC source: 0001209191-18-062126 · doc4.xml · derivative · entry 3 Owens Julia C. · CIK 0001760219 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 151,600 Underlying: Common Stock · 151,600 shares Expires 2026-01-27 F5 · price: Received in connection with the Merger in exchange for a stock option to acquire 2,037,648 shares of Millendo common stock for $0.33 per share. F4 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to the option vested on January 28, 2017, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| December 07, 2018 Filed Dec 11, 2018 19:49 UTC |
Owens Julia C.Director · President and CEO
|
GrantEmployee Stock Option (right to buy) · Derivative | 60,179 | Not disclosed Strike: $1.08 | Not disclosed |
DisclosureSEC source: 0001209191-18-062126 · doc4.xml · derivative · entry 2 Owens Julia C. · CIK 0001760219 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,179 Underlying: Common Stock · 60,179 shares Expires 2022-08-29 F3 · price: Received in connection with the Merger in exchange for a stock option to acquire 808,867 shares of Millendo common stock for $0.08 per share. F2 · derivative.exercise_date: Fully vested. Read SEC document |
| December 07, 2018 Filed Dec 11, 2018 19:49 UTC |
Owens Julia C.Director · President and CEO
|
GrantCommon Stock | 74,400 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-062126 · doc4.xml · nonDerivative · entry 1 Owens Julia C. · CIK 0001760219 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,400 F1 · price: Received in exchange for 1,000,000 shares of Millendo Therapeutics, Inc. ("Millendo") common stock in connection with merger of Millendo Therapeutics, Inc. into the Issuer (the "Merger"). Read SEC document |
| December 07, 2018 Filed Dec 12, 2018 00:36 UTC |
Dable Habib JDirector
|
GrantStock Option (right to buy) · Derivative | 14,880 | Not disclosed Strike: $16.40 | Not disclosed |
DisclosureSEC source: 0001209191-18-062107 · doc4.xml · derivative · entry 1 Dable Habib J · CIK 0001690773 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,880 Underlying: Common Stock · 14,880 shares Expires 2028-09-20 F2 · price: Received in connection with the merger of Millendo Therapeutics, Inc. ("Millendo") into the Issuer in exchange for a stock option to acquire 200,000 shares of Millendo common stock for $1.22 per share. F1 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to the option shall vest on September 21, 2019, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| December 07, 2018 Filed Dec 11, 2018 19:35 UTC |
Arcudi III Louis JChief Financial Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 74,400 | $0.00 Strike: $10.40 | $0.00 |
DisclosureSEC source: 0001209191-18-062105 · doc4.xml · derivative · entry 1 Arcudi III Louis J · CIK 0001419350 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,400 Underlying: Common Stock · 74,400 shares Expires 2028-12-06 F1 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to the option shall vest on November 1, 2019, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.